Quantcast
Last updated on April 23, 2014 at 20:10 EDT

Latest Upsher-Smith Laboratories Inc. Stories

2013-08-07 12:27:08

MAPLE GROVE, Minn., Aug. 7, 2013 /PRNewswire/ -- There has been a great deal of media coverage surrounding heart health and niacin, leaving some consumers confused about its benefits, according to leading cardiologist, Dr. Carl Lavie, Medical Director of Cardiac Rehabilitation and Prevention at the John Ochsner Heart and Vascular Institute, New Orleans, LA. For cholesterol-conscious consumers who are serious about optimizing heart health, Dr. Lavie stands by his long-term...

2013-08-06 12:24:32

MAPLE GROVE, Minn., Aug. 6, 2013 /PRNewswire/ -- Dara Torres, five-time Olympic swimmer, will return to the training facility in Mission Viejo, California, where she first began her epic career, to kick off AmLactin(®) Alpha-Hydroxy Skin Care's support for U. S. Masters Swimming at their Summer national championship meet. Torres serves as brand ambassador for AmLactin, the #1 moisturizer brand recommended by dermatologists for rough, dry skin(1). (Logo:...

2013-06-24 16:27:11

Findings Presented at 30th International Epilepsy Congress MAPLE GROVE, Minn., June 24, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., (Upsher-Smith) today announced the presentation of Phase I data supporting dose-proportional pharmacokinetics, consistent drug levels, and favorable tolerability of its investigational drug, USL255 (extended-release topiramate), across a wide range of doses in healthy subjects. USL255 is specifically engineered to provide convenient once-daily...

2013-06-24 08:28:48

Extension Study Offers Patients Experiencing Seizure Clusters Continued Access to USL261 MAPLE GROVE, Minn., June 24, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., (Upsher-Smith) today announced that it is enrolling patients in its open-label safety extension study to ARTEMIS1 (Acute Rescue Therapy in Epilepsy with Midazolam Intranasal Spray), a global Phase III clinical trial for USL261, a novel, investigational formulation of the benzodiazepine midazolam. USL261 is...

2013-06-05 12:31:34

MAPLE GROVE, Minn., June 5, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. today announced that it is the recipient of a Distribution Industry Award for Notable Achievements in Healthcare (DIANA) given by the Healthcare Distribution Management Association (HDMA). The Company was presented with a DIANA for the "Best Overall Branded Pharmaceutical Product Manufacturer with Sales to Healthcare Distributors of Less Than $300 Million." The Company was also recognized as the First Merit...

2013-05-20 16:25:52

New Focus of Upsher-Smith.com Captures and Celebrates Life Moments MAPLE GROVE, Minn., May 20, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., a specialty pharmaceutical company committed to the development of new treatments for diseases of the central nervous system, today announced the launch of its newly designed website, upsher-smith.com. The new site celebrates life's moments through images and narratives. As part of the company's mission statement - Advancing...

2013-04-29 08:28:30

Greater awareness of epilepsy and sleep disorders may help prevent misdiagnosis and mistreatment MAPLE GROVE, Minn., April 29, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., today announced the addition of the topic Sleep Disorders and Epilepsy to its epilepsy-focused educational website, Epilog.us. The site now features a review of the relationship between epilepsy and sleep disorders. To view the multimedia assets associated with this release, please click:...

2013-04-25 08:35:36

MAPLE GROVE, Minn., April 25, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), in partnership with The Epilepsy Foundation of Minnesota (EFMN), today announced that the Pleschourt family from Dundas, Minnesota was awarded sponsorship to attend The Epilepsy Foundation's National Walk for Epilepsy(®) in Washington, D.C. on April 20, 2013. (Photo: http://photos.prnewswire.com/prnh/20130425/NY01600) Mark and Melissa Pleschourt's 13-year-old daughter, Taylor, was...

2013-04-25 08:35:33

MAPLE GROVE, Minn., April 25, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), in partnership with The Epilepsy Foundation of New Jersey (EFNJ), today announced that the Pretz family from Brielle, New Jersey was awarded sponsorship to attend The Epilepsy Foundation's National Walk for Epilepsy(®) in Washington, D.C. on April 20, 2013. (Photo: http://photos.prnewswire.com/prnh/20130425/NY01596) Todd and Ellen Pretz's 17-year-old daughter, Kelly, was diagnosed with...

2013-03-19 12:27:26

USL261 Demonstrated Improved Bioavailability of Midazolam, Similar Pharmacodynamic Effects, and Comparable Tolerability as Compared with Injectable Midazolam Administered Intranasally in Healthy Volunteers MAPLE GROVE, Minn., March 19, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., (Upsher-Smith) today announced that Phase I data for USL261 (intranasal midazolam) in healthy volunteers were presented at the Annual American Academy of Neurology (AAN) Meeting in San Diego, CA....